Chemoinformaics analysis of 1H-Indole-3-ethanamine, 7-chloro-
| Molecular Weight | 194.665 | nRot | 2 |
| Heavy Atom Molecular Weight | 183.577 | nRig | 19 |
| Exact Molecular Weight | 194.061 | nRing | 2 |
| Solubility: LogS | -3.706 | nHRing | 1 |
| Solubility: LogP | 4.182 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 28.4147 |
| nHD | 2 | BPOL | 11.5453 |
| QED | 0.448 |
| Synth | 2.761 |
| Natural Product Likeliness | 1.227 |
| NR-PPAR-gamma | 0.409 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.635 |
| Pgp-sub | 0.015 |
| HIA | 0.014 |
| CACO-2 | -5.074 |
| MDCK | 0.0000246 |
| BBB | 0.039 |
| PPB | 1.00227 |
| VDSS | 0.58 |
| FU | 0.00955407 |
| CYP1A2-inh | 0.921 |
| CYP1A2-sub | 0.103 |
| CYP2c19-inh | 0.761 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.721 |
| CYP2c9-sub | 0.431 |
| CYP2d6-inh | 0.68 |
| CYP2d6-sub | 0.273 |
| CYP3a4-inh | 0.408 |
| CYP3a4-sub | 0.148 |
| CL | 11.937 |
| T12 | 0.839 |
| hERG | 0.024 |
| Ames | 0.535 |
| ROA | 0.642 |
| SkinSen | 0.908 |
| Carcinogencity | 0.631 |
| EI | 0.924 |
| Respiratory | 0.325 |
| NR-Aromatase | 0.86 |
| Antiviral | No |
| Prediction | 0.74857 |